Trials / Sponsors / HitGen Inc.
HitGen Inc.
Industry · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Clinical Trial of HG146 Administered to Participants with Adenoid Cystic Carcinoma Adenoid Cystic Carcinoma, Head and Neck Cancer | Phase 2 | 2024-12-13 |
| Unknown | Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma Solid Tumor, Lymphoma | Phase 1 | 2023-07-28 |
| Recruiting | A Study of HG381 Administered to Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2021-10-18 |
| Terminated | A Study of HG146 Capsule in Chinese Subjects with Relapsed and Refractory Multiple Myeloma Multiple Myeloma, Relapsed and Refractory Multiple Myeloma | Phase 1 | 2019-01-12 |